
Pre- and Post-Surgery Immunotherapy Enhances Outcomes in Head and Neck Cancer
In a groundbreaking advancement for head and neck cancer treatment, a new phase 3 clinical trial led by Dana-Farber Brigham Cancer Center has unveiled compelling evidence that immunotherapy administered before, during, and after surgery significantly …